Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up.


OBJECTIVE To test the effectiveness and long term safety of cannabinoids in multiple sclerosis (MS), in a follow up to the main Cannabinoids in Multiple Sclerosis (CAMS) study. METHODS In total, 630 patients with stable MS with muscle spasticity from 33 UK centres were randomised to receive oral Delta(9)-tetrahydrocannabinol (Delta(9)-THC), cannabis… (More)


6 Figures and Tables